Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Lovaas JD, Zhu L, Chiao CY, Byles V, Faller DV, Dai Y.

Prostate. 2013 Apr;73(5):522-30. doi: 10.1002/pros.22592. Epub 2012 Oct 4.

2.

Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.

Yu L, Wang CY, Shi J, Miao L, Du X, Mayer D, Zhang J.

Endocrinology. 2011 Mar;152(3):773-81. doi: 10.1210/en.2010-1239. Epub 2011 Jan 19.

PMID:
21248144
3.

Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.

Nakane K, Fujita Y, Terazawa R, Atsumi Y, Kato T, Nozawa Y, Deguchi T, Ito M.

Int J Urol. 2012 Jan;19(1):71-9. doi: 10.1111/j.1442-2042.2011.02888.x. Epub 2011 Nov 3.

4.

Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.

Yang JL, Lin JH, Weng SW, Chen JC, Yang JS, Amagaya S, Funayana S, Wood WG, Kuo CL, Chung JG.

Mol Med Rep. 2013 May;7(5):1403-8. doi: 10.3892/mmr.2013.1380. Epub 2013 Mar 20.

PMID:
23525212
5.

Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.

Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P, Persson JL.

J Natl Cancer Inst. 2008 Jul 16;100(14):1022-36. doi: 10.1093/jnci/djn214. Epub 2008 Jul 8.

6.

Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.

Cui Y, Li J, Zheng F, Ouyang Y, Chen X, Zhang L, Chen Y, Wang L, Mu S, Zhang H.

Med Sci Monit. 2016 Feb 5;22:380-6.

7.

SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.

Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, Dai Y.

Oncogene. 2012 Oct 25;31(43):4619-29. doi: 10.1038/onc.2011.612. Epub 2012 Jan 16.

8.

Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.

Moroz A, Delella FK, Almeida R, Lacorte LM, Fávaro WJ, Deffune E, Felisbino SL.

PLoS One. 2013 Dec 30;8(12):e84757. doi: 10.1371/journal.pone.0084757. eCollection 2013.

9.

Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.

Ling YX, Tao J, Fang SF, Hui Z, Fang QR.

Eur J Cancer Prev. 2011 Jan;20(1):9-17. doi: 10.1097/CEJ.0b013e32833ebaa0.

PMID:
20881502
10.

Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer.

Baptista T, Graça I, Sousa EJ, Oliveira AI, Costa NR, Costa-Pinheiro P, Amado F, Henrique R, Jerónimo C.

Oncotarget. 2013 Oct;4(10):1673-85.

11.

MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2.

Chen Q, Zhao X, Zhang H, Yuan H, Zhu M, Sun Q, Lai X, Wang Y, Huang J, Yan J, Yu J.

Mol Carcinog. 2015 Nov;54(11):1292-300. doi: 10.1002/mc.22204. Epub 2014 Aug 23.

PMID:
25154741
12.

Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation.

Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow WS, Wang C, McCue PA, McBurney MW, Pestell RG.

Cancer Res. 2011 Feb 1;71(3):964-75. doi: 10.1158/0008-5472.CAN-10-3172. Epub 2010 Dec 28.

13.

Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Jung-Hynes B, Nihal M, Zhong W, Ahmad N.

J Biol Chem. 2009 Feb 6;284(6):3823-32. doi: 10.1074/jbc.M807869200. Epub 2008 Dec 15.

14.
15.

NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways.

Yang M, Gu YY, Peng H, Zhao M, Wang J, Huang SK, Yuan XH, Li J, Sang JL, Luo Q, Huang C.

J Cancer Res Clin Oncol. 2015 Jun;141(6):1037-47. doi: 10.1007/s00432-014-1865-2. Epub 2014 Nov 29.

PMID:
25432142
16.

SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.

Zhao G, Cui J, Zhang JG, Qin Q, Chen Q, Yin T, Deng SC, Liu Y, Liu L, Wang B, Tian K, Wang GB, Wang CY.

Gene Ther. 2011 Sep;18(9):920-8. doi: 10.1038/gt.2011.81. Epub 2011 Jun 16.

PMID:
21677689
17.

NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response.

Wang B, Hasan MK, Alvarado E, Yuan H, Wu H, Chen WY.

Oncogene. 2011 Feb 24;30(8):907-21. doi: 10.1038/onc.2010.468. Epub 2010 Oct 18.

PMID:
20956937
18.

MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition.

Sun L, Kokura K, Izumi V, Koomen JM, Seto E, Chen J, Fang J.

EMBO Rep. 2015 Jun;16(6):689-99. doi: 10.15252/embr.201439792. Epub 2015 Apr 13.

19.

Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.

Wegiel B, Jiborn T, Abrahamson M, Helczynski L, Otterbein L, Persson JL, Bjartell A.

PLoS One. 2009 Nov 23;4(11):e7953. doi: 10.1371/journal.pone.0007953.

20.

Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.

Adissu HA, McKerlie C, Di Grappa M, Waterhouse P, Xu Q, Fang H, Khokha R, Wood GA.

Prostate. 2015 Dec;75(16):1831-43. doi: 10.1002/pros.23056. Epub 2015 Sep 1.

PMID:
26332574

Supplemental Content

Support Center